Self-Monitoring and Monetary Reinforcement Increases Rate of Walking in Adults with Intellectual Disabilities
This study used an ABAB design to evaluate a session-based self-monitoring and monetary reinforcement intervention for increasing walking by adults with intellectual disabilities at a worksite. The intervention resulted in a noticeable increase in the rate of walking for all five participants, with consistent increases for four participants. This study also evaluated if staff could correctly implement the intervention. The staff member implemented the treatment with high fidelity, and the higher rates of walking observed when the researchers implemented the intervention were maintained when staff implemented the intervention. The participants and the staff member rated the intervention as effective and acceptable.
Conclusions: Psychiatric comorbidity is very common in epileptic patients and depending on the type of diagnosed epilepsy, various symptoms are expressed. Furthermore, psychological stress is more observable in adolescents with epilepsy. For patients with epilepsy, mental health care and seizure control is extremely important in the prevention of serious mental disabilities. PMID: 31961263 [PubMed - as supplied by publisher]
Recurrent stroke is becoming an increasingly important public health issue owing to the increased risk of disability and death. However, population-based studies investigating the rate of recurrent stroke in China are rare. We explored the rate and determinants of recurrent stroke within 1 and 5 years after the initial stroke in a rural population in China. Data for stroke events were obtained from the Tianjin Brain Study, conducted between 1992 and 2016. The age-standardized rates of recurrent stroke within the first year and the first 5 years after the initial stroke were calculated for this period. Determinants of recur...
DiscussionThe adapted MAM-36 showed adequate psychometric properties. However, indications of problematic targeting to PwMS with low disability emerged. For this reason, use of the scale appears to be more suitable among patients with moderate-to-severe disability.
JAMES MOORE is the actor famed for playing the role of Ryan Stocks in the popular show Emmerdale. James revealed a disability he suffers from. What is it and what are the symptoms?
Conditions: Cervical Disc Herniation; Pain, Neuropathic Intervention: Drug: Combination Product: triamcinolone and saline Sponsor: Marmara University Active, not recruiting
Complaining about work is a popular pastime. It can be a way of bonding with others who also have impossible bosses, annoying coworkers, or miserable working conditions. But few of us would want to be unfairly barred from all that work can offer. The benefits of a job go beyond economic support. In the best cases, jobs can provide structure, social ties and social support, welcome challenges, and maybe even a sense of self and a meaningful life. If you have a mental illness, though, you may find it particularly difficult to land a job, even if you want to work and you are qualified for the jobs that interest you. According...
These two classes of chemicals are linked to millions of cases of intellectual disability in the US alone. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Publication date: February 2020Source: Research in Developmental Disabilities, Volume 97Author(s):
One pharmacist ’s experience of discrimination, owing to their disabilities, shows that the profession still has a long way to go towards equality.
Mental and substance use disorders account for more than 7% of the global burden of disease and are the leading cause of disability in young people (1,2). In terms of lost productivity, the cumulative disability due to depression alone exacts an annual cost of $201 billion in the United States (3). The toll on young people is especially alarming; in the United States, the suicide rate among 15- to 24-year-olds has tripled since the 1950s (4). This alarming situation has created an escalating sense of urgency for innovations in clinical neuroscience.